GGrantIndex
Sort

326,823 grants matching clinical trial

Phase I Molecular and Clinical Pharmacodynamic Trials ET-CTN

$2,015,876
Edward M Newman · Beckman Research Institute/City Of Hope · UM1 · FY2018 · CA

Leadership Center Administration

$2,015,775
Robert A Wood · Johns Hopkins University · UM2 · FY2020 · AI

Test of Rapamycin in Aging Dogs (TRIAD)

$2,015,762
Kate Elizabeth Creevy · Texas A&M Agrilife Research · R01 · FY2025 · AG

Randomized Trial: Maternal Vitamin D Supplementation to Prevent Childhood Asthma

$2,015,731
Scott T Weiss · Brigham And Women'S Hospital · U01 · FY2010 · HL

Central Hub for Kidney Precision Medicine - Administrative Core

$2,015,621
Jonathan Himmelfarb · University Of Washington · U2C · FY2017 · DK

Biology and Therapy of High Risk Neuroblastoma

$2,015,534
Robert C Seeger · Children'S Hospital Of Los Angeles · P01 · FY2011 · CA

KwaZulu-Natal Clinical Trials Unit

$2,015,382
Quarraisha Abdool Karim · Centre/Aids Programme/Res/South Africa · UM1 · FY2025 · AI

From therapeutic mechanisms to unraveling the pathophysiology of MS

$2,015,349
Bibiana Bielekova · National Institute Of Neurological Disorders And Stroke · ZIA · FY2018 · NS

The Delaware Comprehensive Sickle Cell Research Center

$2,015,028
Marie J. Stuart · Nemours Children'S Hospital, Delaware · P20 · FY2015 · GM

Safety and Preliminary Efficacy Imaging Clinical Trials

$2,015,000
Massachusetts General Hospital · N01 · FY2008 · CA

Sorafenib for Hepatopulmonary Syndrome

$2,014,988
Steven M Kawut · University Of Pennsylvania · UM1 · FY2014 · HL

Multi-Center Group to Study Acute Liver Failure in Child

$2,014,896
Children'S Hosp Pittsburgh/Upmc Hlth Sys · U01 · FY2005 · DK

Neurobiology and Target Validation of Novel Therapeutic Agents in Mood Disorders

$2,014,694
Carlos Zarate · National Institute Of Mental Health · ZIA · FY2017 · MH

Kaiser Washington Vaccine and Treatment Evaluation Unit - DMID 21-0012

$2,014,564
Lisa A Jackson · Kaiser Foundation Research Institute · UM1 · FY2021 · AI

Telemonitoring to improve heart failure outcomes

$2,014,503
Harlan M Krumholz · Yale University · R01 · FY2006 · HL

Autism Adaptive Community-based Treatment to Improve Outcomes using Navigators (ACTION) Network

$2,014,481
Amy M Wetherby · Florida State University · R01 · FY2020 · HD

Dominantly Inherited Alzheimer Network: Clinical Core

$2,014,480
John Morris · Washington University · U19 · FY2022 · AG

COMPREHENSIVE SICKLE CELL CENTER OF MANHATTAN

$2,014,448
Columbia University Health Sciences · P60 · FY2000 · HL

Immunopathogenesis of Fungal Infections

$2,014,260
Michail Lionakis · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI

Vascular Immunobiology Mechanistic and Translational Studies

$2,014,258
Yogendra Kanthi · National Heart, Lung, And Blood Institute · ZIA · FY2025 · HL

Clinical Trials of Vaccines for Respiratory Syncytial Virus and Related Viruses

$2,014,197
Peter Leon Collins · National Institute Of Allergy And Infectious Diseases · ZIA · FY2012 · AI

University of Rochester Center for AIDS Research

$2,014,115
Stephen Dewhurst · University Of Rochester · P30 · FY2016 · AI

TRIP-PCI: PAR1 Pepducin-Based Interventions in Arterial Thrombosis

$2,013,904
Athan Kuliopulos · Tufts Medical Center · P50 · FY2014 · HL

University of North Carolina - Chlamydia Vaccine Initiative (UNC-CVI)

$2,013,333
Toni Darville · Univ Of North Carolina Chapel Hill · U19 · FY2023 · AI

A Comparative Effectiveness & Long-term Health Study in Wisconsin Smokers

$2,013,059
Michael C Fiore · University Of Wisconsin-Madison · R01 · FY2016 · HL